If you've researched weight loss medication, you've probably encountered both Ozempic and Wegovy. They contain the same active ingredient — semaglutide — but are approved for different uses and come in different dosages.
Ozempic is FDA-approved for type 2 diabetes management. Its primary purpose is improving blood sugar control, with weight loss as a significant beneficial side effect. Maximum dose is 2mg weekly. Many physicians prescribe Ozempic off-label for weight loss in patients who don't have diabetes, though this is at the physician's discretion.
Wegovy is FDA-approved specifically for chronic weight management. It uses the same semaglutide at a higher maximum dose of 2.4mg weekly. It was designed and studied specifically for weight loss, with clinical trials showing average weight loss of about 15% of body weight. Wegovy is now available as both an injection and an oral pill.
The main differences are the approved indication (diabetes vs. weight management), the maximum dosage (2mg vs. 2.4mg), the dosing escalation schedule (Wegovy has a more gradual increase), and insurance coverage (diabetes medications are more commonly covered). The molecule is identical — the difference is how they're packaged, dosed, and marketed.
If you have type 2 diabetes and want to lose weight, Ozempic addresses both. If you don't have diabetes and your primary goal is weight loss, Wegovy is the specifically approved option. Your physician will recommend the appropriate medication based on your health profile, insurance situation, and weight loss goals.
Both have experienced supply fluctuations. Cash-pay prices vary significantly by provider. At TheMensRX, we prescribe the most appropriate and accessible option for each patient, and our pricing is straightforward — no hidden fees or surprise charges.
Related: GLP-1 Weight Loss Guide · Weight Loss Meds vs Diet · Weight Loss
Ready to take the next step?
Join the Waitlist — Get 50% Off